Mobilized Leukopak

Logo

Mobilized Leukopak

Mobilized leukopaks are enriched leukapheresis products collected under IRB-approved protocols using the Spectra Optia® Apheresis System. Donors receive G-CSF, plerixafor, or both to mobilize CD34⁺ HSPCs from bone marrow into peripheral blood.

The result is a high-yield leukopak enriched in CD34⁺ cells, T cells, B cells, monocytes, and NK cells — offering greater TNC counts and broader immune subsets than non-mobilized products. Mobilized leukopaks are ideal for early-stage preclinical research in regenerative medicine and cell therapy.

To support your workflow, Miltenyi Biotec offers:

  • High CD34+ cell yield from a single donor
  • Flexible mobilization schedules, including 4–5 day regimens with collection on days 5 or 6; or dual collections on days 5 & 6, or 6 & 7
  • Donor-specific add-ons, including HLA type, CMV status, age, sex, and ethnicity

Collected in the US under IRB-approved standards
All blood products sold in North America are collected in the US under IRB-approved standards ensuring consistent sample integrity, ethical compliance, and peace of mind for your research and development programs. Please note that MACS® Quality Blood Products are only available in US and Canada.

Choose your blood product

Please note that MACS Quality Blood Products are only available in the US and Canada.

1 product found

|

You have previously chosen International as your location.
What do you want to do?